These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36517029)

  • 1. Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions.
    Nakayama Y; Mizuno H; Sawa N; Suwabe T; Yamanouchi M; Ikuma D; Hasegawa E; Hoshino J; Sekine A; Oba Y; Kono K; Kinowaki K; Ohashi K; Suzuki K; Sato Y; Shimizu A; Yamaguchi Y; Ubara Y
    Intern Med; 2023 Aug; 62(15):2223-2229. PubMed ID: 36517029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
    CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
    Front Immunol; 2019; 10():1489. PubMed ID: 31316523
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
    Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
    Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
    Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T
    BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case report of TAFRO syndrome].
    Zhou GP; Zhou QY; Zhu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):814-817. PubMed ID: 34393252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
    Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
    Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
    CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomeruloid hemangioma associated with TAFRO syndrome.
    Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
    Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.